| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | J05AP06 |
| UNII: | S9X0KRJ00S |
| InChI Key | XRWSZZJLZRKHHD-WVWIJVSJSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C35H46ClN5O9S |
| Molecular Weight | 748.3 |
| AlogP | 3.85 |
| Hydrogen Bond Acceptor | 10.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 11.0 |
| Polar Surface Area | 182.33 |
| Molecular species | ACID |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 51.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S29 family
Serine protease S29 regulatory subfamily
|
- | 1-1 | - | - | - | |
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S29 family
|
- | 1-1 | - | - | - | |
|
Unclassified protein
|
1-4 | - | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hepatitis C | 3 | D006526 | ClinicalTrials |
| Hepatitis C, Chronic | 3 | D019698 | ClinicalTrials |
| Infections | 2 | D007239 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 630420-16-5 |
| ChEBI | 134723 |
| ChEMBL | CHEMBL2105735 |
| DrugBank | DB11586 |
| DrugCentral | 4889 |
| FDA SRS | S9X0KRJ00S |
| Guide to Pharmacology | 10882 |
| PDB | 2R9 |
| PharmGKB | PA166128168 |
| PubChem | 16076883 |
| SureChEMBL | SCHEMBL2630655 |
| ZINC | ZINC000085540202 |